Phreesia
Overview
Patient intake and activation platform whose Network Solutions business delivers pharma brand messaging to patients and caregivers at the point of care during check-in, supporting more than 180 million patient check-ins in 2025. Phreesia data shows 40% of patients ask their doctor about pharma brands seen at the point of care.
Notable
Publicly traded (NYSE: PHR); Veeva Crossix case study attributed 17% of a campaign's new-to-brand prescriptions to Phreesia point-of-care placements at 2% of media spend.
Key services
- point-of-care patient messaging
- condition-targeted brand campaigns
- patient activation and education
- new-to-brand conversion measurement
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Phreesia? Share your experience in a short, confidential interview.
Share your experience